AFXCarl Zeiss Meditec AG Inhaber-Aktien o.N.
31.74EUR-1.24%Mkt Cap: 3.06B $P/E: 23.46

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products a…

HeadlineSourceTime
Yesterday
finanzen.net
finanzen.at
finanzen.ch
This week
finanzen.net
finanzen.net
sharedeals.de
finanzen.net
finanzen.net
FinanzNachrichten.de
FFinanztrends
finanzen.net
finanzen.net
Older
finanzen.net
Wallstreet Online
finanzen.net
finanzen.net
finanzen.net
finanzen.net
finanzen.net
finanzen.net
HHeidenheimer Zeitung
finanzen.net
finanzen.net
finanzen.net
finanzen.net
Wallstreet Online
simplywall.st
Wallstreet Online
Finanzen.net
Carl Zeiss Meditec Q3 Earnings Call Highlights

Carl Zeiss Meditec (ETR:AFX) reported lower revenue and profitability for the first nine months of fiscal 2025/2026, as foreign-exchange effects, weakness in ophthalmology consumables and the suspension of certain bifocal intraocular lens sales in China weighed on results. Order entry totaled €1.60

MarketBeat
Investing.com Deutsch
PPressReader
Finanzen.net
WELT
finanzen.ch
boerse.de
FinanzNachrichten.de
Finanzen.net
Finanzen.net
finanztrends.de
finanzen.ch
MarketScreener Deutschland
MarketScreener Deutschland
finanzen.ch
boerse.de
FinanzNachrichten.de
Carl Zeiss says restructuring could affect up to 1,000 jobs

A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.

MedTech Dive
Earnings Miss: Carl Zeiss Meditec AG Missed EPS And Analysts Are Revising Their Forecasts

Last week, you might have seen that Carl Zeiss Meditec AG ( ETR:AFX ) released its first-quarter result to the market...

Simply Wall St.